UCLA.edu
Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.
Profiles
Home
About
Help/FAQs
Search Options
UC Davis
UCI
UCLA
UCSD
UCSF
All UC Health
USC
All
Everything
Research
Concepts
Awards
People
UC Health People
UC Davis People
UCI People
UCLA People
UCSD People
UCSF People
USC People
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Kara Chew
Concepts (220)
Back to Profile
Concepts are derived automatically from a person's publications.
Cloud
Categories
Timeline
Details
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
Abatacept
Acquired Immunodeficiency Syndrome
Adaptive Clinical Trials as Topic
Adipose Tissue
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Aging
AIDS Vaccines
Alanine Transaminase
Alcohol Drinking
Ambulatory Care
Analgesics, Opioid
Animals
Anti-Bacterial Agents
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing
Antibodies, Viral
Antigens, CD
Antigens, Differentiation, Myelomonocytic
Anti-HIV Agents
Anti-Retroviral Agents
Antiviral Agents
Aorta
Bacteremia
Biological Assay
Biomarkers
Body Mass Index
California
Canada
Cardiomyopathies
Cardiovascular Diseases
Case-Control Studies
CD4 Lymphocyte Count
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Child
Cholesterol, LDL
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Cohort Studies
Coinfection
Community-Acquired Infections
Comorbidity
Control Groups
Coronary Artery Disease
Coronary Disease
Critical Illness
Cross-Sectional Studies
Demography
Disease Progression
Disease Transmission, Infectious
DNA, Viral
Double-Blind Method
Drug Combinations
Drug Resistance, Viral
Drug Therapy, Combination
Dysbiosis
Dyspnea
Electrocardiography
End Stage Liver Disease
Epitopes, B-Lymphocyte
Feedback, Physiological
Female
Fibrosis
Follow-Up Studies
Gastrointestinal Microbiome
Genome, Viral
Genotype
Half-Life
Headache
Heart Atria
Hepacivirus
Hepatitis B
Hepatitis B virus
Hepatitis C
Hepatitis C Antibodies
Hepatitis C, Chronic
Hepatitis, Viral, Human
Hepatoblastoma
HIV
HIV Antibodies
HIV Infections
HIV Long-Term Survivors
HIV Seronegativity
HIV Seropositivity
HIV-1
Homosexuality, Male
Hospital Mortality
Hospitalization
Hospitals, Public
Hospitals, Urban
Humans
Hydroxychloroquine
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Immune Evasion
Immunocompromised Host
Immunoglobulin G
Immunotherapy
Inappropriate Prescribing
Incidence
Indazoles
Infant
Inflammation
Infliximab
Insurance, Health
Interferon-alpha
Kinetics
Laboratories
Limit of Detection
Linear Models
Lipids
Lipoproteins, LDL
Liposomes
Liver
Liver Cirrhosis
Liver Neoplasms
Logistic Models
Longitudinal Studies
Los Angeles
Macaca mulatta
Macrophage Activation
Macrophages
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Male
Metabolic Diseases
Middle Aged
Multicenter Studies as Topic
Mutation
Myanmar
Myocardial Infarction
Myocardium
Nanoparticles
National Institutes of Health (U.S.)
Non-alcoholic Fatty Liver Disease
Opiate Substitution Treatment
Opioid-Related Disorders
Outpatients
Pain
Pandemics
Patient Acceptance of Health Care
Phosphoproteins
Phylogeny
Plaque, Atherosclerotic
Pneumonia
Polyethylene Glycols
Polypharmacy
Practice Guidelines as Topic
Predictive Value of Tests
Pre-Exposure Prophylaxis
Pregnancy
Pregnancy Complications, Infectious
Prevalence
Prisoners
Proof of Concept Study
Propensity Score
Proprotein Convertase 9
Proprotein Convertases
Prospective Studies
Proton Magnetic Resonance Spectroscopy
Qualitative Research
Quinolines
Randomized Controlled Trials as Topic
Real-Time Polymerase Chain Reaction
Receptors, Cell Surface
Recombinant Proteins
Recurrence
Reference Values
Remission, Spontaneous
Renal Insufficiency, Chronic
Research Design
Retrospective Studies
Rhode Island
Ribavirin
Risk Assessment
Risk Factors
Ritonavir
RNA
RNA, Messenger
RNA, Viral
San Francisco
Sensitivity and Specificity
Seroepidemiologic Studies
Severity of Illness Index
Sexual and Gender Minorities
Sexual Behavior
Societies, Medical
Sofosbuvir
Spectrum Analysis
Spike Glycoprotein, Coronavirus
Substance Abuse, Intravenous
Surveys and Questionnaires
Survival Analysis
Sustained Virologic Response
Symptom Assessment
Tenofovir
Time Factors
Treatment Outcome
Triazines
Triazoles
Triglycerides
Tryptophan
Tumor Necrosis Factor-alpha
United States
Unsafe Sex
Vaccination
Vaccines, DNA
Vaccines, Synthetic
Ventricular Dysfunction, Left
Ventricular Function, Left
Veterans
Viral Load
Viremia
Virology
Virus Replication
Young Adult
Kara's Networks
Concepts (220)
Derived automatically from this person's publications.
Coinfection
Hepatitis C
Hepatitis C, Chronic
Antiviral Agents
Antibodies, Neutralizing
Explore
_
Co-Authors (47)
People in Profiles who have published with this person.
Currier, Judith
UCLA
Daar, Eric
UCLA
Smith, David
UCSD
Bhattacharya, Debika
UCLA
Ramirez, Sydney
UCSD
Explore
_
Similar People (60)
People who share similar concepts with this person.
Terrault, Norah
UCSF
Terrault, Norah
USC
Saab, Sammy
UCLA
Deeks, Steven
UCSF
Martin, Natasha
UCSD
Explore
_
Same Department
Caldemeyer, Lauren
Gallup, Cecily
Ganz, David
Lee, John
Reed, Jarred
Search Department
_